Similarly, better disease control achievement were possible by training and management of the patients in T2DM and hypertension.[11,12] The decreased HbA1c after management were consistent with HbA1c change after MMC follow-up management in MMC sub-centers in Ningbo Affiliated First hospital.[7] FPG, 2hPG and other metabolic outcomes showed no changes before and after management, especially 2hPG, which might be related to the fact that all 2hPG test in the study were 2-hour blood glucose by steamed bread meal insulin release test. The gene discussed is INS; the disease is type 2 diabetes mellitus.